Considering the total number of thyroid procedures in Germany (100000 - 120000 cases per year), TachoSil® is a valuable tool to support surgical haemostasis, avoiding lymph leaks and support speech-nerve saving approaches. The aim of this study was to evaluate a patient and procedure profile where TachoSil® is most beneficial.
Study Type
OBSERVATIONAL
Enrollment
482
Assessment of TachoSil® by the Surgeon With Respect to Handling, Utility and Satisfaction in the Operation, Documented Using 10 Point Numerical Rating Scales
Handling (1= very good to 10= very poor) Satisfaction (1= very satisfied to 10= totally unsatisfied) Utility (1= very useful to 10= completely useless)
Time frame: after surgery
Pharmacoeconomic Benefits as Assessed by the Surgeon
Question: What benefits resulted from the application of TachoSil® during this operation? (different categories to be answered with yes/no)
Time frame: peri- and post-surgery until hospital discharge
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Nycomed Deutschland GmbH
Aschaffenburg, Germany
Nycomed Deutschland GmbH
Aschersleben, Germany
Nycomed Deutschland GmbH
Bad Berka, Germany
Nycomed Deutschland GmbH
Bad Salzungen, Germany
Nycomed Deutschland GmbH
Bad Tölz, Germany
Nycomed Deutschland GmbH
Baden-Baden, Germany
Nycomed Deutschland GmbH
Bayreuth, Germany
Nycomed Deutschland GmbH
Berlin, Germany
Nycomed Deutschland GmbH
Berlin, Germany
Nycomed Deutschland GmbH
Berlin, Germany
...and 122 more locations